Player is loading...

Embed

Embed code

Transcriptions

Note: this content has been automatically generated.
00:00:00
thank you very much Christopher this
00:00:02
very very unclear and fascinating talk
00:00:04
with lots of thought-provoking
00:00:07
statements i'm sure there are many
00:00:10
questions are there any questions in the
00:00:12
audience i was telling us that
00:00:22
recognition is superior to to dopamine
00:00:26
yeah and then I probably mr. point that
00:00:28
then you tell us that we should use WT
00:00:31
mean why not
00:00:32
norepinephrine well I think you should
00:00:35
we can use both depending on the on the
00:00:38
situation where you're in when you have
00:00:39
higher vascular resistance then you you
00:00:43
first need something to improve
00:00:45
myocardial contractility and sometimes
00:00:48
you it makes sense to use both the rumen
00:00:52
to increase positive inotropic support
00:00:54
norepinephrine to try trait the vascular
00:00:58
resistance
00:00:59
I think that's individual clinical that
00:01:00
judgment according to the hammer dynamic
00:01:02
situation a certain hour of like the
00:01:05
baby actually usually newborn babies
00:01:12
usually am especially gram-negative that
00:01:14
they have high peripheral vascular
00:01:15
resistance and if I don't hug you into
00:01:19
the club open on the weekend often given
00:01:24
cope to question if these are allowed
00:01:34
first regarding this million of study
00:01:37
and was million monotherapy or was it
00:01:40
our combined with another drop
00:01:44
well as I as far as i remember well in
00:01:48
India enterovirus that was monotherapy
00:01:50
the Vietnam trial
00:01:51
yes and in there india dose-finding
00:01:54
studies it was always add onto usually
00:01:58
epinephrine
00:01:59
ok and the second question
00:02:01
got the food management in sepsis you
00:02:04
said that we should be very close with a
00:02:07
adeboye char fluids and Drita under
00:02:11
echocardiographic our control and
00:02:13
cartography control and what is your
00:02:16
suggestion for the bases are free that
00:02:20
we're giving should we reduce the mass
00:02:22
play also we need 250 per kilo
00:02:26
how do you do that the basic solution
00:02:28
you're going well I i wouldn't change
00:02:30
the basic solution we just keep it
00:02:32
running and then add extra fluid
00:02:36
according to what you see in the echo
00:02:38
and if we see already that our heart is
00:02:43
over loaded with food
00:02:45
well then you should have then you then
00:02:46
of course you should use an eye drop but
00:02:49
you should do you would do always look
00:02:53
at the acting out i hope i think that
00:02:55
because you from the outside it's
00:02:56
difficult to tell
00:02:57
okay thank you very much
00:03:01
let's define it want to add a word of
00:03:04
caution and to make sure that not
00:03:06
everybody goes home using intoxicated
00:03:08
the moment because you have to look at
00:03:10
the numbers in exasperation small it's
00:03:12
the small studies and most of them are
00:03:14
from Poland you showed an example where
00:03:16
very few small studies short and
00:03:19
positive effect and then there was a
00:03:20
large RC done and the effect is gone so
00:03:22
controlling to publication bias and I
00:03:25
think we need a large country a study
00:03:27
but I i think it's very difficult to do
00:03:29
such as such a trial because overall
00:03:32
acceptance which meets extended
00:03:35
hemodynamic support is a rare we talked
00:03:39
a lot about this but most babies don't
00:03:41
have severe sepsis they came they
00:03:43
receive antibiotics a little bit of
00:03:44
sodium chloride and that's fine
00:03:46
so the severe sepsis is a rare if you
00:03:49
look at the apple trials even they had
00:03:51
to have recruited many many centers and
00:03:53
every Center just had two or three cases
00:03:56
which they added to their to the trial
00:03:59
and such a try is very very expensive
00:04:02
because you have to initiate so many
00:04:04
centers and I don't think that ever
00:04:08
it's such a trial will be financed at
00:04:11
least in in the lodge light in in
00:04:13
northern North America or Europe just
00:04:15
too costly
00:04:18
thank you very much i think you're right
00:04:21
mate

Share this talk: 


Conference program

Welcome Words
M. Roth-Kleiner, R. Arlettaz Mieth
10 Jan. 2017 · 9:33 a.m.
526 views
Short Reports Introduction
E. Giannoni, T. Karen, Resp. Lausanne, Zürich
10 Jan. 2017 · 9:38 a.m.
Association of Axonal Injury and Preeclampsia
Katrina Evers, Neonatology UKBB
10 Jan. 2017 · 9:39 a.m.
182 views
Q&A - Association of Axonal Injury and Preeclampsia
Katrina Evers, Neonatology UKBB
10 Jan. 2017 · 9:44 a.m.
102 views
Retinopathy of Prematurity
Roland Gerull, Bern
10 Jan. 2017 · 9:47 a.m.
154 views
Q&A - Retinopathy of Prematurity
Roland Gerull, Bern
10 Jan. 2017 · 9:54 a.m.
Parechovirus Infection: A Rare Cause of Neonatal Encephalitis (in French)
Dr Truant AS, Cheffe de clinique, Néonatologie, CHUV, Lausanne
10 Jan. 2017 · 9:59 a.m.
350 views
Q&A - Parechovirus Infection: A Rare Cause of Neonatal Encephalitis
Dr Truant AS, Cheffe de clinique, Néonatologie, CHUV, Lausanne
10 Jan. 2017 · 10:04 a.m.
234 views
112 views
Genetic Susceptibility to Neonatal Group B Streptococcal Disease
Alessandro Borghesi, Fellay lab, EPFL
10 Jan. 2017 · 10:17 a.m.
131 views
Q&A - Genetic Susceptibility to Neonatal Group B Streptococcal Disease
Alessandro Borghesi, Fellay lab, EPFL
10 Jan. 2017 · 10:25 a.m.
Psychomotor Development in Children Prenatally Exposed to Methadone
G. Grand-Guillaume-Perrenoud, Pediatrics, Children's University Hospital Geneva
10 Jan. 2017 · 10:27 a.m.
Q&A - Psychomotor Development in Children Prenatally Exposed to Methadone
G. Grand-Guillaume-Perrenoud, Pediatrics, Children's University Hospital Geneva
10 Jan. 2017 · 10:34 a.m.
Introduction to Christoph Berger's Presentation
C. Kind, R. Gerull, Resp. St.Gallen, Bern
10 Jan. 2017 · 10:37 a.m.
Vertical Infections: An Update
Christoph Berger, Zürich
10 Jan. 2017 · 10:40 a.m.
253 views
Q&A - Vertical Infections: An Update
Christoph Berger, Zürich
10 Jan. 2017 · 11:15 a.m.
Introduction to Eric Giannoni's Presentation
R. Pfister, S. Kämpfen, Resp. Geneva, Basel
10 Jan. 2017 · 11:44 a.m.
Sepsis, Antibiotics and Resistances: Where Are We?
Christoph Bührer, Berlin
10 Jan. 2017 · 2:21 p.m.
145 views
Use and Abuse of Antibiotics in Neonatology
Martin Stocker, Lucerne
10 Jan. 2017 · 2:50 p.m.
291 views
Panel Discussion : Controversies on Use of Antibiotics in Neonatology
Martin Stocker, Christoph Berger, Eric Giannoni, Christoph Bührer
10 Jan. 2017 · 3:10 p.m.
105 views
Introduction to Christoph Bührer's Presentation
Romaine Arlettaz Mieth , Neonatologist, Zürich, President of the Organizing Committee
10 Jan. 2017 · 3:47 p.m.
Evidence-Based Haemodynamic Management in Neonatal Sepsis
Christoph Bührer, Berlin
10 Jan. 2017 · 3:48 p.m.
416 views
Q&A - Evidence-Based Haemodynamic Management in Neonatal Sepsis
Christoph Bührer, Berlin
10 Jan. 2017 · 4:16 p.m.
SwissNeoDose Project
Marc Pfister, Ped Pharmacology, UKBB
10 Jan. 2017 · 4:20 p.m.
112 views
Awards (Case of the Year; Milupa; Best Poster Case Report; Best Oral Short Presentation) & Closing Comments
Matthias Roth-Kleiner, CHUV, President of the SSN
10 Jan. 2017 · 4:30 p.m.

Recommended talks

Opening
Matthias Roth-Kleiner, Lausanne
16 Jan. 2018 · 9:34 a.m.
121 views